The Kayode Williams Lab conducts translational research on neuromodulation. We primarily examine the mechanisms and efficacy of spinal cord stimulation in treating neuropathic pain, peripheral neuropathies and peripheral vascular disease. Our clinical trials explore spinal cord stimulation in the treatment of painful diabetic neuropathy and the treatment of critical non-reconstructible critical leg ischemia. We also have a longstanding interest in the business of medicine and seek to enhance value propositions for hospitals and physician groups through more effective management of resources.
Work in the Michael Erdek Lab explores interventional pain management and cancer pain management. Our studies focus on the assessment and interventional treatment of cancer-related pain and intrathecal therapy for spasticity resistant to management by oral medications. We also conduct research on the use of spinal cord stimulation as a treatment for neuropathic pain, refractory angina pectoris and refractory peripheral vascular disease.
Work in the Sivanesan Neuromodulation Laboratory (SNL) focuses on developing electrical stimulation therapies for treating neuropathic pain conditions and discovering novel applications for patients suffering from painful conditions. We study mechanisms of all modalities of spinal cord stimulation in the laboratory and aim to rapidly translate these discoveries to patient care. This bench to bedside approach facilitates a unique integration of the latest science with the clinical care of patients.
Work in the Srinivasa Raja Lab seeks to better understand both the peripheral and central mechanisms that cause neuropathic pain, including various methods for treatment. A large focus of our research is on exploring the role of opioid and adrenergic receptor mechanisms in the management of chronic neuropathic pain. Our team also studies the mechanisms of spinal cord stimulation for treating chronic pain, and we have conducted controlled clinical trials in an effort to improve evidence-based practices for pharmacological treatment of neuropathic pain.